4 stocks under $10 to target in 2014

Inexpensive small caps are a time-tested group of performers. Here are several that could rank among next year's biggest winners.

By StreetAuthority Dec 12, 2013 10:49AM
Droplet Falling from Pipette into Test Tube © Andrew Douglas, Radius Images, Getty ImagesBy David Sterman                                                        

I like to track all the stocks I write about, maintaining watch lists by various categories. One of my favorite categories, "small cap stocks under $10," has been a tried-and-true group for me over the years.

Here are four of these stocks I'm focusing on right now. Each of them appears to have solid upside in the year ahead.

1. Maxwell Technologies (MXWL)
In the face of an air pollution epidemic, the Chinese government is finally getting serious. Any technologies that can sharply cut emissions from power plants and transportation are getting a fresh look, and this company could be a clear beneficiary. Maxwell makes ultra-capacitors, which can deliver huge amounts of power in short bursts. The products are especially well-suited in transportation, in vehicles such as city buses.

China has already been a strong customer in the past, as this article written by a sales executive at the company notes.

But China has delayed renewing a subsidy program for hybrid buses. Shares have traded off a bit in the past few months in the face of such delays.

I look at this stock's performance in 2014 in a binary fashion. If China doesn't renew those subsidies, then shares are likely to be rangebound. But if China moves ahead with the renewed subsidization of hybrid buses using ultra-capacitors, shares would quickly move into the low teens in anticipation of firmly rising sales in 2014 and 2015.

2. Novavax (NVAX)
I profiled this biotech back in September as one of three low-priced stocks with huge potential upside. While Merge Healthcare (MRGE) has traded down in the face of still-weak hospital spending, the other two picks have fared quite well.

I think much of the near-term upside for Lionbridge Technologies (LIOX) has already played out, but I see continued momentum for Novavax. As I noted back in September, the company is pursuing treatments for several kinds of viruses, and thus far has delivered very impressive clinical testing data.

Now that we may be looking at the early signs of another bird flu epidemic in Asia, Novavax may start to gain a considerable amount of buzz. The current strain, known as H7N9, has been the target of the company's recent efforts, and if this pandemic spreads, you'll be hearing a lot more about Novavax.

In mid-November, Novavax published a notice in the New England Journal of Medicine that cited protection against bird flu for 81% of people who took the company's vaccine. As a company executive noted: "Past H7-based vaccine candidates have been poorly immunogenic and thus could not be advanced as viable vaccine candidates. This risk appears to have been overcome by our H7N9 adjuvanted VLP vaccine."

Looking beyond this potential catalyst, Novavax is conducting several clinical trials, setting the stage for updates over the next few quarters. Each time the company delivers positive efficacy and safety data, shares should tick a bit higher. Of course, the best catalyst would be a partnership with a major pharmaceutical company, which would validate Novavax's technology and strengthen its balance sheet.?

3. Alacer Gold (ALIAF)
Some of my best investment ideas come from my astute research colleagues here at StreetAuthority. And this recent pick from Dave Forest, who helms our Junior Resource Advisor newsletter, got my attention. Though I am bit wary of gold stocks at the moment, this gold producer holds an irresistible value proposition.

This miner, which is virtually debt-free, is among the industry's lowest-cost producers, meaning it's solidly profitable at current gold prices -- and would still likely remain profitable even if gold prices pushed 20% lower from here. Dave noted a few months ago that "the company's cash cost of production in the second quarter of 2013 was an ultra-low $395 per ounce of gold." Even accounting for overhead, Dave figures that the "all-in" cost is $700 per ounce.

Still, the ongoing drop in gold prices, to a recent $1,230 an ounce, hasn't spared this stock in the sector-wide sell-off. The company's market value has fallen below $600 million (and less than $400 million when net cash is excluded), but Dave thinks the company can generate $200 million in annual profits. If he's right, then this stock is one of the deepest bargains on the market.

4. Axcelis Technologies (ACLS)
Lastly, I remain a big fan of this chip equipment provider, which I profiled on our sister site ProfitableTrading.com, roughly a month ago. As I noted back then, backlog is growing, customer interest in its new product lines is increasing, and sales and profits look poised for a solid upturn in 2014. We'll have to wait until early February to hear a quarterly business update, but I expect to hear even more bullishness from management about the traction that new products are getting.

Risks to consider: Small-cap stocks are often economically sensitive, so we'll need to see a positive macro backdrop in 2014 for stocks like these to move into favor.

Action to take: Each of these four companies are pursuing very different niches, but all show signs of delivering solid financial results in 2014. I've got them on my small-cap watch list and see them as some of the biggest potential gainers for the year ahead.

More from StreetAuthority
Dec 13, 2013 11:56AM
Dear Mr. Sterman:

WOW!!!  Under $10?  I'll take ONE!!!  No, on second thought, I don't want to deprive you, Mr. Sterman.  You go ahead and buy it.

I appreciate your offer, but, no thanks, I think I'll pas on this offer:<)

Insincerely yours,

Staying Stockless, KYA (Keep Your Advice)

Dec 13, 2013 2:41AM
Go Ahead David (the author), invest in your Maxwell stock. I would never invest in a company dependent on the Chinese. The other 3 picks are shady as well.

 My 2 picks are FCEL and CPST, small caps on the cusp of finally making money. The products they make can be used throughout the world, and are "green products".  The world is taking notice of these products, and that's my bet for 2014.

Dec 13, 2013 11:01AM
How do I get your job? The gold stock doesn't have anyone following it
Dec 16, 2013 6:21PM
I think I'll keep it in the mattress for now - Thanks anyway........
I've read these articles before about these "up & coming" companies that are suppose to "bloom" into bigger, more profitable companies. They suggest you but the stock while it is at a low price because once this "up & coming" company takes off, you are sure to make some money. The only problem is, is that these companies stay "flat" and never really take off in price like they are suppose to. Small time stock investors like myself get dragged into things like this in hopes of making money like everyone else and get disappointed. I think twice now when it comes to purchasing "bargain" stocks. 
Dec 12, 2013 3:45PM
What's the matter, MSN... didn't like the last Tsunami Wave of perceived negativity? Thousands of Kool Aid articles aren't going to change an overwhelming air of corruption and failure. 
What kind of fool invests in a rigged arena? Cash out and RUN. 
Dec 12, 2013 3:46PM
Also... nobody except THE FED using QE can drop the losses on the ow from 100+ to 50 in a few minutes. That's fake money with REAL consequences bailing wealth... not you or me. Time for a scumbag BBQ... or are they manipulators? I forget.  
Please help us to maintain a healthy and vibrant community by reporting any illegal or inappropriate behavior. If you believe a message violates theCode of Conductplease use this form to notify the moderators. They will investigate your report and take appropriate action. If necessary, they report all illegal activity to the proper authorities.
100 character limit
Are you sure you want to delete this comment?


Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.


StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

125 rated 1
267 rated 2
455 rated 3
612 rated 4
682 rated 5
695 rated 6
632 rated 7
472 rated 8
279 rated 9
147 rated 10

Top Picks

TAT&T Inc9



Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.